<?xml version="1.0" encoding="UTF-8"?>
<ref id="B20-viruses-10-00211">
 <label>20.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Grunewald</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Kantarjian</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Du</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Faucher</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Tarassoff</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Plunkett</surname>
    <given-names>W.</given-names>
   </name>
  </person-group>
  <article-title>Gemcitabine in leukemia: A phase I clinical, plasma, and cellular pharmacology study</article-title>
  <source>J. Clin. Oncol.</source>
  <year>1992</year>
  <volume>10</volume>
  <fpage>406</fpage>
  <lpage>413</lpage>
  <pub-id pub-id-type="doi">10.1200/JCO.1992.10.3.406</pub-id>
  <?supplied-pmid 1740680?>
  <pub-id pub-id-type="pmid">1740680</pub-id>
 </element-citation>
</ref>
